{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"49.515","value":"100.2"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"14"}],"units":"Participants"}],"description":"Cmax of melphalan at dose of 9 mg/m2 on Cycle 2/Day 4","dispersionType":"Standard Deviation","groups":[{"description":"Melphalan 9 mg/m2 on day 1, 2, 3 and 4 of 6-week cycle up to 9 cycles","id":"OG000","title":"Melphalan"}],"paramType":"MEAN","populationDescription":"Pharmacokinetics-evaluable population: 14 participants were included in pharmacokinetics-evaluable population during Cycle 2","reportingStatus":"POSTED","timeFrame":"Day 4 of Cycle 2","title":"Maximum Observed Plasma Concentration (Cmax) of Melphalan - Phase I","type":"SECONDARY","unitOfMeasure":"ng/mL"}